다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Clearside Biomedical Inc (CLSD)
Clearside Biomedical Inc (CLSD) 뉴스

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CLSD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/21	20:05	GlobeNewswire Inc.	Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/11	05:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/10	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/10	05:05	GlobeNewswire Inc.	Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:CLSD	Clearside Biomedical Inc
2024/05/09	05:15	GlobeNewswire Inc.	Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference	NASDAQ:CLSD	Clearside Biomedical Inc
2024/04/30	20:05	GlobeNewswire Inc.	Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024	NASDAQ:CLSD	Clearside Biomedical Inc
2024/04/16	20:05	GlobeNewswire Inc.	Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors	NASDAQ:CLSD	Clearside Biomedical Inc
2024/04/02	20:05	GlobeNewswire Inc.	Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:CLSD	Clearside Biomedical Inc
2024/03/18	20:05	GlobeNewswire Inc.	Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer	NASDAQ:CLSD	Clearside Biomedical Inc
2024/03/13	05:05	GlobeNewswire Inc.	Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/29	21:05	GlobeNewswire Inc.	Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/09	07:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/09	06:52	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/07	22:00	GlobeNewswire Inc.	Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering	NASDAQ:CLSD	Clearside Biomedical Inc
2024/02/02	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2024/01/20	08:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLSD	Clearside Biomedical Inc
2024/01/20	05:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CLSD	Clearside Biomedical Inc
2023/12/29	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2023/12/14	21:05	GlobeNewswire Inc.	Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/14	06:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/14	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/14	06:05	GlobeNewswire Inc.	Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/08	21:05	GlobeNewswire Inc.	Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/08	06:20	GlobeNewswire Inc.	Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/04	01:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/04	01:00	GlobeNewswire Inc.	BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/02	20:05	GlobeNewswire Inc.	Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting	NASDAQ:CLSD	Clearside Biomedical Inc
2023/11/01	20:05	GlobeNewswire Inc.	Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD	NASDAQ:CLSD	Clearside Biomedical Inc
2023/10/31	20:05	GlobeNewswire Inc.	Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023	NASDAQ:CLSD	Clearside Biomedical Inc
2023/10/16	20:05	GlobeNewswire Inc.	Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting	NASDAQ:CLSD	Clearside Biomedical Inc

검색 관련기사 보기:NASDAQ:CLSD

1 2 3 4 5 6 7 8 9 10 다음 >>

Allied Gaming and Entert...

Vontobel Financial Produ...

Societe Generale Effekten

TPC Consolidated

Summit Healthcare Acquis...

WisdomTree Brent Crude Oil

OMRX Government Debt

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관